Cargando…
KPNA2 expression is a potential marker for differential diagnosis between osteosarcomas and other malignant bone tumor mimics
BACKGROUND: Karyopherin α2 (KPNA2), a member of the karyopherin α family, has been studied in several cancers but has not yet been substantially investigated in malignant bone tumors. The purpose of the current study was to evaluate the KPNA2 expression level and its utility as a novel diagnostic bi...
Autores principales: | Jiang, Lucen, Liu, Jianghuan, Wei, Qingzhu, Wang, Yiyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661224/ https://www.ncbi.nlm.nih.gov/pubmed/33176814 http://dx.doi.org/10.1186/s13000-020-01051-6 |
Ejemplares similares
-
Geranylgeranylacetone promotes human osteosarcoma cell apoptosis by inducing the degradation of PRMT1 through the E3 ubiquitin ligase CHIP
por: Jiang, Lucen, et al.
Publicado: (2021) -
Decreased Expression of Karyopherin-α 1 is Related to the Malignant Degree of Cervical Cancer and is Critical for the Proliferation of Hela Cells
por: Jiang, Lucen, et al.
Publicado: (2022) -
IRF2 Destabilizes Oncogenic KPNA2 to Modulate the Development of Osteosarcoma
por: Xia, Shuchi, et al.
Publicado: (2022) -
Nuclear import of prototype foamy virus transactivator Bel1 is mediated by KPNA1, KPNA6 and KPNA7
por: Duan, Jihui, et al.
Publicado: (2017) -
Nuclear import of prototype foamy virus transactivator Bel1 is mediated by KPNA1, KPNA6 and KPNA7
por: Duan, Jihui, et al.
Publicado: (2016)